Protein Arrays I: Antibody Arrays

Part of the Methods in Molecular Biology book series (MIMB, volume 1654)


Antibody arrays represent one of the very early protein array systems where antibodies are used to capture and detect target proteins in a high-throughput platform. The development of high-quality antibodies, nanomaterial-based novel detection probes, as well as innovative imaging technologies and computational tools has tremendously improved the sensitivity, specificity, and robustness of antibody arrays during the past decade. In this protocol we will incorporate the most updated innovations and developments of antibody arrays into the step-by-step experimental procedures. This includes antibody printing, sample preparation, array detection, as well as imaging and data analysis. Antibody array could be used for cytokine profiling or mapping of phosphorylation, glycosylation, or other post-translational modifications of target proteins.

Key words

Antibody array Cytokine profiling Kinome mapping Glycome mapping Biomarkers 



This work was partly supported by a grant from the Lupus Research Institute to T.W. and a startup fund from the University of Houston to T.W.


  1. 1.
    Orchekowski R, Hamelinck D, Li L, Gliwa E, VanBrocklin M, Marrero JA, Woude GFV, Feng Z, Brand R, Haab BB (2005) Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res 65(23):11193–11202CrossRefPubMedGoogle Scholar
  2. 2.
    Borrebaeck CA, Wingren C (2014) Antibody array generation and use. Methods Mol Biol 1131:563–571CrossRefPubMedGoogle Scholar
  3. 3.
    Mueller C, Liotta LA, Espina V (2010) Reverse phase protein microarrays advance to use in clinical trials. Mol Oncol 4(6):461–481CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Wu T, Ding H, Han J, Arriens C, Wei C, Han W, Pedroza C, Jiang S, Anolik J, Petri M, Sanz I, Saxena R, Mohan C (2016) Antibody-array-based proteomic screening of serum markers in systemic lupus erythematosus: a discovery study. J Proteome Res 15(7):2102–2114. doi: 10.1021/acs.jproteome.5b00905 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Wu T, Du Y, Han J, Singh S, Xie C, Guo Y, Zhou XJ, Ahn C, Saxena R, Mohan C (2013) Urinary angiostatin—a novel putative marker of renal pathology chronicity in lupus nephritis. Mol Cell Proteomics 12(5):1170–1179. doi: 10.1074/mcp.M112.021667 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Zong Y, Zhang S, Chen H-T, Zong Y, Shi Y (2007) Forward-phase and reverse-phase protein microarray. Methods Mol Biol 381:363–374PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  1. 1.Department of Biomedical EngineeringUniversity of HoustonHoustonUSA
  2. 2.Department of Clinical LaboratoryThe People’s Hospital of Guangxi Zhuang Autonomous RegionNanningChina
  3. 3.National pharmacology Laboratory of Chinese MedicineCollege of Basic Medical Sciences, Wannan Medical CollegeWuhuChina
  4. 4.Department of NursingFujian Health CollegeFuzhouChina

Personalised recommendations